pISSN 1976-2283
eISSN 2005-1212

Download original image
Fig. 4. Long-term results for (A) clinical remission, (B) clinical response, (C) mucosal healing, (D) inflammatory bowel disease questionnaire (IBDQ) response, and (E) steroids-free remission in patients exposed to adalimumab versus placebo.

CI, confidence interval.

Gut and Liver 2016;10:262~274 https://doi.org/10.5009/gnl15042
© Gut and Liver